Form 4: Omada Health CFO Sells Shares Under 10b5-1 Plan
Insider Trading Disclosure
Omada Health's Chief Financial Officer, Steven L. Cook, sold 1,884 shares of common stock for $13.94 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Steven L. Cook, Chief Financial Officer of Omada Health, Inc., disposed of 1,884 shares of common stock.
- The transaction occurred on March 13, 2026, at a price of $13.94 per share.
- Following this transaction, Mr. Cook beneficially owns 200,512 shares of Omada Health common stock directly.
- The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Cook on August 15, 2025.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive disclosure. While it's an insider sale, the execution under a pre-arranged 10b5-1 plan mitigates any negative sentiment, indicating a planned financial move rather than a reaction to new company information.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
StockSavvy.ai notes that insider sales executed under a Rule 10b5-1 trading plan are pre-scheduled and often reflect personal financial planning rather than a change in management's outlook on the company's prospects. Such sales are generally viewed as less indicative of future stock performance compared to unscheduled insider transactions.
Stakeholder Impact
- Shareholders: May observe a minor, routine insider sale, which is unlikely to significantly impact sentiment given the 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 08/15/2025 | Date Reporting Person adopted the 10b5-1 trading plan. |
| 03/13/2026 | Date of transaction where 1,884 shares of common stock were sold. |
| 03/17/2026 | Date the Form 4 filing was signed. |
Recommendation
holdThe Form 4 filing details a routine insider sale by the CFO under a pre-arranged 10b5-1 plan. This type of transaction is generally not considered a strong indicator for investment decisions and does not provide sufficient new information to alter an existing investment thesis. Therefore, a 'hold' recommendation is appropriate, pending further company-specific or market-wide developments.
Keywords
Omada Health, OMDA, Steven L. Cook, CFO, Insider Sale, Form 4, 10b5-1 Plan, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.